Riskpilot← Back to searchSign inGet full accessTruly Translational Sweden AB
ABActiveOrg 5568601123Scheelevägen 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20112 employees
Revenue 2024
SEK 3M
0% vs 2023
EBITDA margin
37.6%
+168% vs 2023
Equity ratio
30.8%
Financial strength
Net profit 2024
SEK 723K
+424% vs 2023
| Revenue | SEK 3M | +0% |
| EBITDA | SEK 1,1M | +168% |
| Net profit | SEK 723K | +424% |
| Total assets | SEK 6,1M | +6% |
| Equity | SEK 1,9M | +29% |
| Employees | 2 | — |
Legal name
Truly Translational Sweden AB
Org number
5568601123
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28 juli 2011
Share capital
SEK 60 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Brunmark, Anna Charlott von Wachenfeldt, Karin Agnetai förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska erbjuda kund-specifika tjänster till andra företag, offentlig sektor och myndigheter inom Life Science. Tjänsterna är fokuserade på translationell forskning, dvs. övergången från preklinisk till klinisk verksamhet. Våra tjänster kan indelas i tre huvudsakliga produkt-områden: konsultation, pre-kliniska modeller i djur och biomarkörer i djur och människa.
Address
Scheelevägen 2
Phone
+46464602100
Email
info@trulytranslational.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 174 | 4 199 | 3 099 | 3 000 | 3 000 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 658 | 1 157 | 296 | 422 | 1 129 |
| Depreciation & amort. | −0 | −0 | −37 | −146 | −0 |
| EBIT | 658 | 1 157 | 259 | 276 | 1 129 |
| Net financials | −1 | — | 342 | 75 | 85 |
| Profit before tax | 569 | 931 | 519 | 311 | 910 |
| Tax | −57 | −308 | −156 | −173 | −187 |
| Net profit | 512 | 623 | 363 | 138 | 723 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 503 | 4 866 | 5 402 | 5 724 | 6 086 |
| Equity | 1 228 | 1 552 | 1 615 | 1 453 | 1 876 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 283 | 1 617 | 1 528 | 1 492 | 1 167 |
| Total debt | 1 283 | 1 617 | 1 528 | 1 492 | 1 167 |
EBITDA margin
37.6%
This company
15.8%
Market median
+138% vs market
20202024
Equity ratio
30.8%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
38.5%
This company
18.4%
Market median
+109% vs market
20202024
Net profit margin
24.1%
This company
8.1%
Market median
+198% vs market
20202024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20202024
Debt / equity
2.24×
This company
0.62×
Market median
-261% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JD Auditor Substitute | Auditor Substitute | 2020 |
KA Chief Executive Officer | Chief Executive Officer | 2020 |
PL Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Truly Translational Sweden AB 
Truly Labs ABBoard members of Truly Translational Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Do | Auditor Substitute | 0 companies |
| Karin Agneta von Wachenfeldt | Chief Executive Officer | 0 companies |
| Per Lenny Persson | Chief Auditor | 0 companies |
| Anna Charlott Brunmark | Chairman | 0 companies |
| Hans Patrik Holmqvist | Board of Directors | 0 companies |